Elisabeth Lindner

A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria

Bernd Höppe, Patrick Niaudet, Rémi Salomon et al. · Pediatric Nephrology · 2016 · 83 citations

Antibiotics, Primary Hyperoxaluria, Medicine +3

Effects of <i>Oxalobacter formigenes</i> in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study

Bernd Höppe, Patricia A. Pellikka, Bastian Dehmel et al. · Nephrology Dialysis Transplantation · 2020 · 38 citations

FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study

Klaus Kaczirek, Tudor–Eliade Ciuleanu, Damir Vrbanec et al. · Clinical Colorectal Cancer · 2014 · 29 citations

Tumor Ras, Gastrointestinal Oncology, Medicine +10

Plasma oxalate: comparison of methodologies

Felicity Stokes, Cécile Acquaviva, Bernd Höppe et al. · Urolithiasis · 2020 · 26 citations · Full text

Urine oxalate biological variation in patients with primary hyperoxaluria

Oliver Clifford-Mobley, Anna Sjögren, Elisabeth Lindner et al. · Urolithiasis · 2016 · 24 citations

Urological Research, Urology, Renal Function +6